| Name | Title | Contact Details |
|---|
More commonly known as Columbia County Health System and Dayton General Hospital, the Columbia County Public Hospital District #1 was established in 1960 with the vision and mission of providing high quality healthcare to our local communities. We are a 25-bed, Critical Access Hospital with Level V Trauma Center, Level III Cardiac and Stroke Center designations. Additionally, we are the regions primary wound care and hyperbaric therapy treatment center. Our primary service areas include Dayton, Waitsburg, Starbuck, and the surrounding region. We are comprised of Columbia Family Clinic, Waitsburg Clinic, Booker Rest Home, and Dayton General Hospital with our Rural Health Clinics open for primary care and behavior health services 6 days a week. We are fully staffed with 3 primary care medical doctors, a board-certified emergency medicine doctor, a board-certified pediatrician, 4 mid-level family practice providers, and dermatology focused ARNP. Our Emergency Department is staffed with our employed providers as well as partner physicians. In addition to Acute Care services, we offer inpatient care for sub-acute, Swing Bed patients, which are patients that need a step down from acute care, but still require skilled nursing care and/or various rehabilitation therapies for an extended period. This service allows patients, who may have had a qualifying, Acute hospitalization or surgery, to return to our facility and receive hospital class nursing and rehabilitation services for an extended period.
MedMinder Systems Inc. provides services that simplify medication management and improve medication adherence. We offer an automatic pill dispenser that reminds users when it is time to take their medication through flashes, beeps, text messages & phone calls.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic
Great Plains Orthotics & Prosthetics is a Ames, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mindleap is an advanced digital health platform that helps people connect with mental health specialists that can empower them to thrive and develop habits for a healthy mind. Online mental healthcare brings convenience, improves access to treatments and can lead to more personal breakthroughs. Mindleap`s proprietary platform is designed by clinical psychologists and neuroscientists to provide professional support and personalized treatment for every person.